JP2023158585A - Topical skin preparation - Google Patents
Topical skin preparation Download PDFInfo
- Publication number
- JP2023158585A JP2023158585A JP2022068511A JP2022068511A JP2023158585A JP 2023158585 A JP2023158585 A JP 2023158585A JP 2022068511 A JP2022068511 A JP 2022068511A JP 2022068511 A JP2022068511 A JP 2022068511A JP 2023158585 A JP2023158585 A JP 2023158585A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- extract
- derivatives
- skin
- ingredients
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 230000000699 topical effect Effects 0.000 title abstract description 4
- 239000000284 extract Substances 0.000 claims abstract description 59
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims abstract description 33
- 229960003966 nicotinamide Drugs 0.000 claims abstract description 32
- 235000005152 nicotinamide Nutrition 0.000 claims abstract description 32
- 239000011570 nicotinamide Substances 0.000 claims abstract description 32
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims abstract description 31
- 235000017491 Bambusa tulda Nutrition 0.000 claims abstract description 31
- 241001330002 Bambuseae Species 0.000 claims abstract description 31
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims abstract description 31
- 239000011425 bamboo Substances 0.000 claims abstract description 31
- 239000004480 active ingredient Substances 0.000 claims abstract description 7
- 229920002674 hyaluronan Polymers 0.000 claims description 23
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 22
- 229960003160 hyaluronic acid Drugs 0.000 claims description 22
- 230000015572 biosynthetic process Effects 0.000 claims description 14
- 238000003786 synthesis reaction Methods 0.000 claims description 14
- 230000000694 effects Effects 0.000 abstract description 6
- 230000002087 whitening effect Effects 0.000 abstract description 4
- 230000037303 wrinkles Effects 0.000 abstract description 4
- 206010014970 Ephelides Diseases 0.000 abstract 1
- 208000003351 Melanosis Diseases 0.000 abstract 1
- 206010040880 Skin irritation Diseases 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 230000009759 skin aging Effects 0.000 abstract 1
- 230000036556 skin irritation Effects 0.000 abstract 1
- 231100000475 skin irritation Toxicity 0.000 abstract 1
- -1 emulsification aids Substances 0.000 description 49
- 238000004519 manufacturing process Methods 0.000 description 35
- 239000004615 ingredient Substances 0.000 description 30
- 210000003491 skin Anatomy 0.000 description 25
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 21
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 19
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 18
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 18
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 15
- 229960005070 ascorbic acid Drugs 0.000 description 14
- 235000014113 dietary fatty acids Nutrition 0.000 description 14
- 239000000194 fatty acid Substances 0.000 description 14
- 229930195729 fatty acid Natural products 0.000 description 14
- 239000008213 purified water Substances 0.000 description 14
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 14
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 13
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 13
- 238000000605 extraction Methods 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 12
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 12
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 12
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 12
- 239000000523 sample Substances 0.000 description 12
- 239000006210 lotion Substances 0.000 description 11
- 235000010323 ascorbic acid Nutrition 0.000 description 10
- 239000011668 ascorbic acid Substances 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 10
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 10
- 235000011187 glycerol Nutrition 0.000 description 10
- 239000000843 powder Substances 0.000 description 10
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 10
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 10
- 229940058015 1,3-butylene glycol Drugs 0.000 description 9
- 235000019437 butane-1,3-diol Nutrition 0.000 description 9
- 238000009472 formulation Methods 0.000 description 9
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 9
- 229960004705 kojic acid Drugs 0.000 description 9
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 9
- 239000004310 lactic acid Substances 0.000 description 9
- 235000014655 lactic acid Nutrition 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 230000001737 promoting effect Effects 0.000 description 9
- 150000003839 salts Chemical class 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 8
- 240000007594 Oryza sativa Species 0.000 description 8
- 235000007164 Oryza sativa Nutrition 0.000 description 8
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 8
- 229960000686 benzalkonium chloride Drugs 0.000 description 8
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 8
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 8
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 8
- 239000003921 oil Substances 0.000 description 8
- 235000019198 oils Nutrition 0.000 description 8
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 8
- 235000009566 rice Nutrition 0.000 description 8
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 7
- 239000002537 cosmetic Substances 0.000 description 7
- 239000006071 cream Substances 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 7
- 229960004889 salicylic acid Drugs 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 230000002195 synergetic effect Effects 0.000 description 7
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 6
- 102000008186 Collagen Human genes 0.000 description 6
- 108010035532 Collagen Proteins 0.000 description 6
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 6
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 6
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 6
- 229960000458 allantoin Drugs 0.000 description 6
- 239000004202 carbamide Substances 0.000 description 6
- 229920001436 collagen Polymers 0.000 description 6
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 6
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 6
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 6
- 229960002216 methylparaben Drugs 0.000 description 6
- 229940042585 tocopherol acetate Drugs 0.000 description 6
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 5
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 5
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 5
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 5
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 5
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 5
- 229930003427 Vitamin E Natural products 0.000 description 5
- 239000004359 castor oil Substances 0.000 description 5
- 235000019438 castor oil Nutrition 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 235000015165 citric acid Nutrition 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 229960000735 docosanol Drugs 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 150000004665 fatty acids Chemical class 0.000 description 5
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 5
- 229930182478 glucoside Natural products 0.000 description 5
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 5
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 5
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 5
- 229940119170 jojoba wax Drugs 0.000 description 5
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 5
- 229940032094 squalane Drugs 0.000 description 5
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 5
- 239000011593 sulfur Substances 0.000 description 5
- 229910052717 sulfur Inorganic materials 0.000 description 5
- 239000011709 vitamin E Substances 0.000 description 5
- 235000019165 vitamin E Nutrition 0.000 description 5
- 229940046009 vitamin E Drugs 0.000 description 5
- 229920001285 xanthan gum Polymers 0.000 description 5
- 235000010493 xanthan gum Nutrition 0.000 description 5
- 239000000230 xanthan gum Substances 0.000 description 5
- 229940082509 xanthan gum Drugs 0.000 description 5
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 4
- 239000002211 L-ascorbic acid Substances 0.000 description 4
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 4
- 229920002125 Sokalan® Polymers 0.000 description 4
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 229960004756 ethanol Drugs 0.000 description 4
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 4
- 239000001685 glycyrrhizic acid Substances 0.000 description 4
- 229960004949 glycyrrhizic acid Drugs 0.000 description 4
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 4
- 235000019410 glycyrrhizin Nutrition 0.000 description 4
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 4
- 235000001968 nicotinic acid Nutrition 0.000 description 4
- 239000011664 nicotinic acid Substances 0.000 description 4
- 229960003512 nicotinic acid Drugs 0.000 description 4
- WNIFXKPDILJURQ-JKPOUOEOSA-N octadecyl (2s,4as,6ar,6as,6br,8ar,10s,12as,14br)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1h-picene-2-carboxylate Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@](C(=O)OCCCCCCCCCCCCCCCCCC)(C)C[C@H]5C4=CC(=O)[C@@H]3[C@]21C WNIFXKPDILJURQ-JKPOUOEOSA-N 0.000 description 4
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 150000004804 polysaccharides Chemical class 0.000 description 4
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical class O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 4
- 239000001509 sodium citrate Substances 0.000 description 4
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 4
- 229960003500 triclosan Drugs 0.000 description 4
- 239000011787 zinc oxide Substances 0.000 description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 3
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 3
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 3
- OYAQUBKYAKSHOA-UHFFFAOYSA-N 2-(2-hydroxy-5-propylphenyl)-4-propylphenol Chemical compound CCCC1=CC=C(O)C(C=2C(=CC=C(CCC)C=2)O)=C1 OYAQUBKYAKSHOA-UHFFFAOYSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 235000004866 D-panthenol Nutrition 0.000 description 3
- 239000011703 D-panthenol Substances 0.000 description 3
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 3
- 235000000069 L-ascorbic acid Nutrition 0.000 description 3
- ILRKKHJEINIICQ-OOFFSTKBSA-N Monoammonium glycyrrhizinate Chemical compound N.O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O ILRKKHJEINIICQ-OOFFSTKBSA-N 0.000 description 3
- 235000021314 Palmitic acid Nutrition 0.000 description 3
- 244000302661 Phyllostachys pubescens Species 0.000 description 3
- 235000003570 Phyllostachys pubescens Nutrition 0.000 description 3
- 241000209504 Poaceae Species 0.000 description 3
- 229920002385 Sodium hyaluronate Polymers 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 229940121363 anti-inflammatory agent Drugs 0.000 description 3
- 239000002260 anti-inflammatory agent Substances 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 229960000271 arbutin Drugs 0.000 description 3
- 229960000541 cetyl alcohol Drugs 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 229960005309 estradiol Drugs 0.000 description 3
- 229930182833 estradiol Natural products 0.000 description 3
- 229940087068 glyceryl caprylate Drugs 0.000 description 3
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 3
- 239000004006 olive oil Substances 0.000 description 3
- 235000008390 olive oil Nutrition 0.000 description 3
- GHBFNMLVSPCDGN-UHFFFAOYSA-N rac-1-monooctanoylglycerol Chemical compound CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229940083542 sodium Drugs 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 229940010747 sodium hyaluronate Drugs 0.000 description 3
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 229930003799 tocopherol Natural products 0.000 description 3
- 235000010384 tocopherol Nutrition 0.000 description 3
- 229960001295 tocopherol Drugs 0.000 description 3
- 239000011732 tocopherol Substances 0.000 description 3
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 description 3
- 150000005207 1,3-dihydroxybenzenes Chemical class 0.000 description 2
- NCLNAHJFXIKYBY-UHFFFAOYSA-N 2-hexyldecyl 16-methylheptadecanoate Chemical compound CCCCCCCCC(CCCCCC)COC(=O)CCCCCCCCCCCCCCC(C)C NCLNAHJFXIKYBY-UHFFFAOYSA-N 0.000 description 2
- ZGSCRDSBTNQPMS-UJURSFKZSA-N 3-O-Ethylascorbic acid Chemical compound CCOC1=C(O)C(=O)O[C@@H]1[C@@H](O)CO ZGSCRDSBTNQPMS-UJURSFKZSA-N 0.000 description 2
- 229940120145 3-o-ethylascorbic acid Drugs 0.000 description 2
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- 102000016942 Elastin Human genes 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N Propene Chemical group CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 description 2
- 244000062793 Sorghum vulgare Species 0.000 description 2
- 244000228451 Stevia rebaudiana Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 2
- 241001135917 Vitellaria paradoxa Species 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 239000006096 absorbing agent Substances 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- LNQVTSROQXJCDD-UHFFFAOYSA-N adenosine monophosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)C(OP(O)(O)=O)C1O LNQVTSROQXJCDD-UHFFFAOYSA-N 0.000 description 2
- 125000005037 alkyl phenyl group Chemical group 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 229940061720 alpha hydroxy acid Drugs 0.000 description 2
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 2
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 2
- 229960002684 aminocaproic acid Drugs 0.000 description 2
- 239000000058 anti acne agent Substances 0.000 description 2
- 229940124340 antiacne agent Drugs 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000001926 citrus aurantium l. subsp. bergamia wright et arn. oil Substances 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 239000000645 desinfectant Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- HYHGLHONPBPZGJ-YCWPWOODSA-L disodium;[(2r)-2-[(1s)-1,2-dihydroxyethyl]-3-hydroxy-5-oxo-2h-furan-4-yl] phosphate Chemical compound [Na+].[Na+].OC[C@H](O)[C@H]1OC(=O)C(OP(O)([O-])=O)=C1[O-] HYHGLHONPBPZGJ-YCWPWOODSA-L 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 239000010642 eucalyptus oil Substances 0.000 description 2
- 229940044949 eucalyptus oil Drugs 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- NFLGAXVYCFJBMK-UHFFFAOYSA-N isomenthone Natural products CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 235000019713 millet Nutrition 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 235000014593 oils and fats Nutrition 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 229960001141 pyrithione zinc Drugs 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 235000019192 riboflavin Nutrition 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 239000002151 riboflavin Substances 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 239000002453 shampoo Substances 0.000 description 2
- 229940057910 shea butter Drugs 0.000 description 2
- 229960004025 sodium salicylate Drugs 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 229950009883 tocopheryl nicotinate Drugs 0.000 description 2
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 2
- 229960000401 tranexamic acid Drugs 0.000 description 2
- PMBRBOODEWULOI-UHFFFAOYSA-N trichloromethanide Chemical compound Cl[C-](Cl)Cl PMBRBOODEWULOI-UHFFFAOYSA-N 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- 229930007845 β-thujaplicin Natural products 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- AVBJHQDHVYGQLS-AWEZNQCLSA-N (2s)-2-(dodecanoylamino)pentanedioic acid Chemical compound CCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC(O)=O AVBJHQDHVYGQLS-AWEZNQCLSA-N 0.000 description 1
- QVSVMNXRLWSNGS-UHFFFAOYSA-N (3-fluorophenyl)methanamine Chemical compound NCC1=CC=CC(F)=C1 QVSVMNXRLWSNGS-UHFFFAOYSA-N 0.000 description 1
- ASWBNKHCZGQVJV-UHFFFAOYSA-N (3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate Chemical class CCCCCCCCCCCCCCCC(=O)OCC(O)COP([O-])(=O)OCC[N+](C)(C)C ASWBNKHCZGQVJV-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 150000005208 1,4-dihydroxybenzenes Chemical class 0.000 description 1
- LNJRMYPOKFOJBQ-UHFFFAOYSA-N 1-(4-tert-butyl-4-methoxycyclohexa-1,5-dien-1-yl)ethanone Chemical compound COC1(C(C)(C)C)CC=C(C(C)=O)C=C1 LNJRMYPOKFOJBQ-UHFFFAOYSA-N 0.000 description 1
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- DGSZGZSCHSQXFV-UHFFFAOYSA-N 2,3-bis(2-ethylhexanoyloxy)propyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(OC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DGSZGZSCHSQXFV-UHFFFAOYSA-N 0.000 description 1
- JPWUIQIFCDAWQX-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(O)CO JPWUIQIFCDAWQX-UHFFFAOYSA-N 0.000 description 1
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 description 1
- ATWGXJGRRXIETI-UHFFFAOYSA-N 2,5-diacetyloxybenzoic acid Chemical compound CC(=O)OC1=CC=C(OC(C)=O)C(C(O)=O)=C1 ATWGXJGRRXIETI-UHFFFAOYSA-N 0.000 description 1
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical class OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- GWHXAZLLZVWMNI-UHFFFAOYSA-N 2-acetyloxy-5-hydroxybenzoic acid Chemical compound CC(=O)OC1=CC=C(O)C=C1C(O)=O GWHXAZLLZVWMNI-UHFFFAOYSA-N 0.000 description 1
- UPHOTCBFZHQJEK-UHFFFAOYSA-N 2-hydroxy-5-propanoyloxybenzoic acid Chemical compound CCC(=O)OC1=CC=C(O)C(C(O)=O)=C1 UPHOTCBFZHQJEK-UHFFFAOYSA-N 0.000 description 1
- JKRDADVRIYVCCY-UHFFFAOYSA-N 2-hydroxyoctanoic acid Chemical compound CCCCCCC(O)C(O)=O JKRDADVRIYVCCY-UHFFFAOYSA-N 0.000 description 1
- HXVCOQUDJKMJQY-UHFFFAOYSA-N 2-octyldodecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC HXVCOQUDJKMJQY-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- NYARJMRXCRSQPJ-UHFFFAOYSA-N 4-(3-methylbutyl)benzene-1,3-diol Chemical compound CC(C)CCC1=CC=C(O)C=C1O NYARJMRXCRSQPJ-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- CSHZYWUPJWVTMQ-UHFFFAOYSA-N 4-n-Butylresorcinol Chemical compound CCCCC1=CC=C(O)C=C1O CSHZYWUPJWVTMQ-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 241001237961 Amanita rubescens Species 0.000 description 1
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 1
- 235000007061 Bambusa multiplex Nutrition 0.000 description 1
- 240000001082 Bambusa multiplex Species 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 1
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 241001520835 Chimonobambusa marmorea Species 0.000 description 1
- 240000003096 Chimonobambusa quadrangularis Species 0.000 description 1
- WJLVQTJZDCGNJN-UHFFFAOYSA-N Chlorhexidine hydrochloride Chemical compound Cl.Cl.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WJLVQTJZDCGNJN-UHFFFAOYSA-N 0.000 description 1
- 241000195628 Chlorophyta Species 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- 229930182843 D-Lactic acid Natural products 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UWTATZPHSA-N D-lactic acid Chemical compound C[C@@H](O)C(O)=O JVTAAEKCZFNVCJ-UWTATZPHSA-N 0.000 description 1
- MDNWOSOZYLHTCG-UHFFFAOYSA-N Dichlorophen Chemical compound OC1=CC=C(Cl)C=C1CC1=CC(Cl)=CC=C1O MDNWOSOZYLHTCG-UHFFFAOYSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 239000006145 Eagle's minimal essential medium Substances 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 229920000855 Fucoidan Polymers 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 241001193798 Katamenes Species 0.000 description 1
- 150000000996 L-ascorbic acids Chemical class 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241001072282 Limnanthes Species 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- ACFGRWJEQJVZTM-LEJBHHMKSA-L Magnesium L-ascorbic acid-2-phosphate Chemical compound [Mg+2].OC[C@H](O)[C@H]1OC(=O)C(OP([O-])([O-])=O)=C1O ACFGRWJEQJVZTM-LEJBHHMKSA-L 0.000 description 1
- 229930182636 Magnolignan Natural products 0.000 description 1
- 235000014435 Mentha Nutrition 0.000 description 1
- 241001072983 Mentha Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- RJUFJBKOKNCXHH-UHFFFAOYSA-N Methyl propionate Chemical compound CCC(=O)OC RJUFJBKOKNCXHH-UHFFFAOYSA-N 0.000 description 1
- 102000007474 Multiprotein Complexes Human genes 0.000 description 1
- 108010085220 Multiprotein Complexes Proteins 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 241000199919 Phaeophyceae Species 0.000 description 1
- 235000006089 Phaseolus angularis Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 235000010792 Phyllostachys aurea Nutrition 0.000 description 1
- 240000002264 Phyllostachys aurea Species 0.000 description 1
- 235000001550 Phyllostachys bambusoides Nutrition 0.000 description 1
- 240000007880 Phyllostachys bambusoides Species 0.000 description 1
- 235000010717 Phyllostachys nigra Nutrition 0.000 description 1
- 240000005827 Phyllostachys nigra Species 0.000 description 1
- 241001087543 Pleioblastus simonii Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 108010020346 Polyglutamic Acid Proteins 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 240000004971 Pseudosasa japonica Species 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 241000206572 Rhodophyta Species 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 235000010794 Sasa kurilensis Nutrition 0.000 description 1
- 244000153801 Sasa kurilensis Species 0.000 description 1
- 235000006577 Semiarundinaria fastuosa Nutrition 0.000 description 1
- 240000001010 Semiarundinaria fastuosa Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 241000543831 Sinobambusa tootsik Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 235000010711 Vigna angularis Nutrition 0.000 description 1
- 240000007098 Vigna angularis Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 241001123263 Zostera Species 0.000 description 1
- OFUHPGMOWVHNPN-QWZFGMNQSA-N [(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] (9z,12z)-octadeca-9,12-dienoate Chemical compound O1[C@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CCC2=C(C)C(OC(=O)CCCCCCC\C=C/C\C=C/CCCCC)=C(C)C(C)=C21 OFUHPGMOWVHNPN-QWZFGMNQSA-N 0.000 description 1
- PAUSGZCRNOTKPK-UHFFFAOYSA-N [5-hydroxy-6-methyl-4-(octanoyloxymethyl)pyridin-3-yl]methyl octanoate Chemical compound CCCCCCCC(=O)OCC1=CN=C(C)C(O)=C1COC(=O)CCCCCCC PAUSGZCRNOTKPK-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- 229940006091 aloe polysaccharide Drugs 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- BJRNKVDFDLYUGJ-ZIQFBCGOSA-N alpha-Arbutin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-ZIQFBCGOSA-N 0.000 description 1
- 229940033280 alpha-arbutin Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229960002298 aminohydroxybutyric acid Drugs 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 229940062909 amyl salicylate Drugs 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- KQZNFGJQTPAURD-NBWQQBAWSA-N ascorbyl dipalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](OC(=O)CCCCCCCCCCCCCCC)[C@H]1OC(=O)C(O)=C1O KQZNFGJQTPAURD-NBWQQBAWSA-N 0.000 description 1
- 239000001168 astaxanthin Substances 0.000 description 1
- 235000013793 astaxanthin Nutrition 0.000 description 1
- 229940022405 astaxanthin Drugs 0.000 description 1
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 229940043253 butylated hydroxyanisole Drugs 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 235000019480 chamomile oil Nutrition 0.000 description 1
- 239000010628 chamomile oil Substances 0.000 description 1
- 229960004504 chlorhexidine hydrochloride Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Polymers OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 description 1
- 125000003074 decanoyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(*)=O 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 229960003887 dichlorophen Drugs 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000004664 distearyldimethylammonium chloride (DHTDMAC) Substances 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- MCPKSFINULVDNX-UHFFFAOYSA-N drometrizole Chemical compound CC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 MCPKSFINULVDNX-UHFFFAOYSA-N 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- HPMLGOFBKNGJAM-ONEGZZNKSA-N ethyl (e)-3-(1h-imidazol-5-yl)prop-2-enoate Chemical compound CCOC(=O)\C=C\C1=CN=CN1 HPMLGOFBKNGJAM-ONEGZZNKSA-N 0.000 description 1
- NYNCZOLNVTXTTP-UHFFFAOYSA-N ethyl 2-(1,3-dioxoisoindol-2-yl)acetate Chemical compound C1=CC=C2C(=O)N(CC(=O)OCC)C(=O)C2=C1 NYNCZOLNVTXTTP-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- YQGDEPYYFWUPGO-UHFFFAOYSA-N gamma-amino-beta-hydroxybutyric acid Chemical compound [NH3+]CC(O)CC([O-])=O YQGDEPYYFWUPGO-UHFFFAOYSA-N 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 125000003104 hexanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 description 1
- 229940099552 hyaluronan Drugs 0.000 description 1
- SUSRLLXAXAIZPH-OBPIAQAESA-N hydroquinone beta-D-glucopyranoside Natural products OC[C@H]1O[C@@H](Cc2ccc(O)cc2)[C@H](O)[C@@H](O)[C@@H]1O SUSRLLXAXAIZPH-OBPIAQAESA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- XSEOYPMPHHCUBN-FGYWBSQSSA-N hydroxylated lecithin Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCC[C@@H](O)[C@H](O)CCCCCCCC XSEOYPMPHHCUBN-FGYWBSQSSA-N 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940071085 lauroyl glutamate Drugs 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 239000004137 magnesium phosphate Substances 0.000 description 1
- 229960002261 magnesium phosphate Drugs 0.000 description 1
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 1
- 235000010994 magnesium phosphates Nutrition 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229940117841 methacrylic acid copolymer Drugs 0.000 description 1
- 229920003145 methacrylic acid copolymer Polymers 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229940017219 methyl propionate Drugs 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 229940105132 myristate Drugs 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- WIBFFTLQMKKBLZ-SEYXRHQNSA-N n-butyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCCC WIBFFTLQMKKBLZ-SEYXRHQNSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 1
- VIKVSUVYUVJHOA-UHFFFAOYSA-N octyl 3-phenylprop-2-enoate Chemical compound CCCCCCCCOC(=O)C=CC1=CC=CC=C1 VIKVSUVYUVJHOA-UHFFFAOYSA-N 0.000 description 1
- 229940060184 oil ingredients Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000019809 paraffin wax Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- RGSFGYAAUTVSQA-UHFFFAOYSA-N pentamethylene Natural products C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920002643 polyglutamic acid Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229940082006 potassium cocoyl glutamate Drugs 0.000 description 1
- YRJKYHIIYRGTCC-UHFFFAOYSA-M potassium;2-hydroxy-4-methoxybenzoate Chemical compound [K+].COC1=CC=C(C([O-])=O)C(O)=C1 YRJKYHIIYRGTCC-UHFFFAOYSA-M 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 235000019719 rose oil Nutrition 0.000 description 1
- 239000010666 rose oil Substances 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 229940057950 sodium laureth sulfate Drugs 0.000 description 1
- 229940078455 sodium lauroyl aspartate Drugs 0.000 description 1
- 229940001584 sodium metabisulfite Drugs 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- IEXXLSKKBWIDAC-ZOWNYOTGSA-M sodium;(3s)-3-(dodecanoylamino)-4-hydroxy-4-oxobutanoate Chemical compound [Na+].CCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CC(O)=O IEXXLSKKBWIDAC-ZOWNYOTGSA-M 0.000 description 1
- SXHLENDCVBIJFO-UHFFFAOYSA-M sodium;2-[2-(2-dodecoxyethoxy)ethoxy]ethyl sulfate Chemical compound [Na+].CCCCCCCCCCCCOCCOCCOCCOS([O-])(=O)=O SXHLENDCVBIJFO-UHFFFAOYSA-M 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- LRUISGPJGHTCRR-LEJBHHMKSA-M sodium;[(2r)-2-[(1s)-1,2-dihydroxyethyl]-3-hydroxy-5-oxo-2h-furan-4-yl] sulfate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(OS([O-])(=O)=O)=C1O LRUISGPJGHTCRR-LEJBHHMKSA-M 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000010677 tea tree oil Substances 0.000 description 1
- 229940111630 tea tree oil Drugs 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003712 vitamin E derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 229960001296 zinc oxide Drugs 0.000 description 1
- 235000014692 zinc oxide Nutrition 0.000 description 1
- 229940043810 zinc pyrithione Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
Abstract
Description
本発明は、複数の成分の組み合わせる配合することで、より高い有効性を発揮する皮膚外用剤に関するものである。 The present invention relates to an external skin preparation that exhibits higher effectiveness by combining a plurality of ingredients.
従来、皮膚外用剤の配合可能な成分として、種々の化合物の使用が提案され、それらを配合した皮膚外用剤(外用医薬品、医薬部外品及び化粧品等)が上市されている。例えば、ビタミンC、ビタミンE等の抗酸化剤;グリチルリチン酸等の抗炎症剤;各種紫外線吸収剤;α-ヒドロキシカルボン酸、胎盤抽出液、γ-アミノ-β-ヒドロキシ酪酸等の細胞賦活成分;コラーゲン、エラスチン、ヒアルロン酸等の細胞外マトリックス成分;尿素等の保湿剤が提案されている。一方で、安全性を考慮して、様々な植物由来成分を配合した皮膚外用剤が提案されている。しかし、それら化合物及び植物由来成分はそれら単独では有効性の点で十分と言えず、高い有効性を発揮する成分の組み合わせが求められている。 BACKGROUND ART Conventionally, the use of various compounds has been proposed as ingredients that can be incorporated into external skin preparations, and external skin preparations (external drugs, quasi-drugs, cosmetics, etc.) containing these compounds have been put on the market. For example, antioxidants such as vitamin C and vitamin E; anti-inflammatory agents such as glycyrrhizic acid; various ultraviolet absorbers; cell-activating ingredients such as α-hydroxycarboxylic acid, placenta extract, and γ-amino-β-hydroxybutyric acid; Extracellular matrix components such as collagen, elastin, and hyaluronic acid; and humectants such as urea have been proposed. On the other hand, in consideration of safety, external skin preparations containing various plant-derived ingredients have been proposed. However, these compounds and plant-derived ingredients alone are not sufficient in terms of effectiveness, and a combination of ingredients that exhibits high effectiveness is required.
本発明者らは、上記従来技術の問題点に鑑みて、皮膚外用剤の有効成分として有効性の高い化合物及び植物由来成分の組み合わせについて鋭意研究を行った。その結果、ナイアシンアミド(別名:ニコチン酸アミド)とタケノコ抽出物の組み合わせが、皮膚外用剤の配合成分として顕著なヒアルロン酸合成促進効果を発揮することを見出した。従来、ナイアシンアミドと植物抽出物の組み合わせ、又はタケノコ抽出物を皮膚外用剤に配合する技術については、特許文献1及び特許文献2により知られているが、ナイアシンアミドとタケノコの抽出物を組み合わせることで、ヒアルロン酸合成促進の相乗効果を発揮することについては知られていなかった。
本発明は、ナイアシンアミド及びタケノコ抽出物を有効成分として含むヒアルロン酸合成促進剤である。 The present invention is a hyaluronic acid synthesis promoter containing niacinamide and bamboo shoot extract as active ingredients.
本発明は、ナイアシンアミド及びタケノコ抽出物を組み合わせることで相乗的なヒアルロン酸合成促進効果を発揮することから、それらを組み合わせて配合することで、有効性の高い皮膚外用剤を提供することができる。 The present invention exhibits a synergistic effect of promoting hyaluronic acid synthesis by combining niacinamide and bamboo shoot extract, and therefore, a highly effective skin preparation can be provided by combining them. .
次に、本発明で使用する「タケノコ」について説明する。「タケノコ」は、イネ科タケ亜科の竹の若芽である。本発明に用いるタケノコの部位としては、可食部分でも、非食部分の皮の部分、又は竹水でも良い。 Next, "bamboo shoots" used in the present invention will be explained. "Takenoko" is the young bud of bamboo, a member of the Poaceae subfamily Bamboo family. The part of the bamboo shoot used in the present invention may be the edible part, the skin of the inedible part, or the bamboo water.
本発明に用いるイネ科タケ亜科のタケとしては、マダケ(Phyllostachys bambusoides)、モウソウチク(Phyllostachys pubescens)、ハチク(Phyllostachys nigra)、ホテイチク(Phyllostachys aurea)、キッコウチク(Phyllostachys heterocycla)、ホウライチク(Bambusa multiplex)、ナリヒラダケ(Semiarundinaria fastuosa)、チシマザサ(ネマガリダケ)(Sasa kurilensis)、トウチク(Sinobambusa tootsik)、シホウチク (Chimonobambusa quadrangularis)、カンチク(Chimonobambusa marmorea)、ヤダケ (Pseudosasa japonica)、メダケ(Pleioblastus simonii)が挙げられるが、本願発明はこれに限るものではない。 Bamboo belonging to the Poaceae subfamily Bamboo family used in the present invention includes Phyllostachys bambusoides, Phyllostachys pubescens, Phyllostachys nigra, Phyllostachys aurea, Phyllostachys heterocycla, Bambusa multiplex, Examples include Semiarundinaria fastuosa, Sasa kurilensis, Sinobambusa tootsik, Chimonobambusa quadrangularis, Chimonobambusa marmorea, Pseudosasa japonica, and Pleioblastus simonii. , main application The invention is not limited to this.
本発明において、タケノコとはイネ科タケ亜科のタケの若芽を指す。本発明で用いるタケノコとして好ましいのは、竹の種によって異なるが、例えば、マダケの場合は、6月~9月に収穫される、地上部が10~500cmのものが好ましく、さらに、地上部から30cm~200cmのものがより好ましい。また、モウソウチクの場合は、3月上旬から~6月下旬に収穫される地上に若芽が出るまでのものが好ましい。上記範囲以上に成長すると、若芽の可食部及び皮が硬くなり、化粧料の成分として好ましくないチロシン量が増えることから、本発明には適さないものとなる。 In the present invention, bamboo shoots refer to young shoots of bamboo belonging to the Poaceae subfamily Bamboo family. Preferable bamboo shoots to be used in the present invention vary depending on the species of bamboo, but for example, in the case of Madake, those with an above-ground part of 10 to 500 cm, which are harvested from June to September, are preferable; More preferably, the length is 30 cm to 200 cm. In addition, in the case of mosochiku, it is preferable to harvest it from early March to late June until young shoots appear on the ground. If the sprout grows beyond the above range, the edible part and skin of the young sprout will become hard and the amount of tyrosine, which is undesirable as a component of cosmetics, will increase, making it unsuitable for the present invention.
抽出物の調製は、タケノコの皮又は可食部を、必要ならば予め水洗して異物を除いた後、そのまま又は乾燥した上、必要に応じて細切又は粉砕し、浸漬法等の常法に従って抽出溶媒と接触させることで行うことが可能である。 To prepare the extract, wash the skin or edible part of the bamboo shoot with water in advance to remove foreign matter, if necessary, then dry it as it is or dry it, then cut or crush it into pieces as necessary, and use a conventional method such as soaking. This can be carried out by contacting with an extraction solvent according to the method.
抽出溶媒としては、水;メタノール、エタノール、プロパノール等の低級アルコール類;エチレングリコール、プロピレングリコール、1,3-ブチレングリコール、グリセリン等の多価アルコール類;酢酸エチル、酢酸ブチル、プロピオン酸メチル等のエステル類;アセトン、メチルエチルケトン等のケトン類;エチルエーテル、イソプロピルエーテル等のエーテル類;n-ヘキサン、トルエン、クロロホルム等の炭化水素系溶媒等が挙げられ、それらは単独で又は二種以上混合して用いられる。 Extraction solvents include water; lower alcohols such as methanol, ethanol, and propanol; polyhydric alcohols such as ethylene glycol, propylene glycol, 1,3-butylene glycol, and glycerin; ethyl acetate, butyl acetate, methyl propionate, etc. Esters; ketones such as acetone and methyl ethyl ketone; ethers such as ethyl ether and isopropyl ether; hydrocarbon solvents such as n-hexane, toluene, and chloroform; these may be used alone or in combination of two or more. used.
それら抽出溶媒のうちでも、皮膚外用剤(化粧料又は医薬部外品)への幅広い適用が可能であるという点からも、本発明においては水或いは水と低級アルコール類又は水と多価アルコール類との混合溶媒の使用が好ましい。 Among these extraction solvents, water, water and lower alcohols, or water and polyhydric alcohols are preferred in the present invention because they can be widely applied to external skin preparations (cosmetics or quasi-drugs). It is preferable to use a mixed solvent with
抽出物の調製に際して、抽出物のpHに特に限定はないが、pH2~8の範囲とすることが好ましい。さらに、抽出物に含まれると化粧料として望ましくない成分であるチロシンの溶解を抑えるという点から、pH2~4の範囲とすることがより好ましい。pHの調製は、前記の抽出溶媒に、乳酸、クエン酸、塩酸、リン酸、硫酸等の酸性調整剤等を配合する事によって行われる。 When preparing the extract, there are no particular limitations on the pH of the extract, but it is preferably in the range of pH 2 to 8. Furthermore, it is more preferable to keep the pH within the range of 2 to 4 from the viewpoint of suppressing the dissolution of tyrosine, which is an undesirable component in cosmetics when contained in the extract. The pH is adjusted by adding an acidic adjuster such as lactic acid, citric acid, hydrochloric acid, phosphoric acid, or sulfuric acid to the extraction solvent.
抽出温度、抽出時間等の抽出条件は、用いる溶媒の種類やpHによっても異なるが、例えば、水を抽出溶媒とする浸漬法の場合であれば、抽出温度は一般的には1~90℃、好ましくは40℃から80℃の範囲であり、抽出時間は、抽出温度が40℃の場合であれば、一般的には0.5~24時間、好ましくは0.5~6時間の範囲である。 Extraction conditions such as extraction temperature and extraction time vary depending on the type of solvent used and pH, but for example, in the case of the immersion method using water as the extraction solvent, the extraction temperature is generally 1 to 90°C, Preferably, the temperature is in the range of 40°C to 80°C, and the extraction time is generally in the range of 0.5 to 24 hours, preferably 0.5 to 6 hours, when the extraction temperature is 40°C. .
上記条件により得られる抽出物は、一般にはpHを4~8に調整した上、これをそのまま皮膚外用剤の成分として使用しても、減圧濃縮等により所望の濃度として使用しても良い。 The pH of the extract obtained under the above conditions is generally adjusted to 4 to 8, and it may be used as it is as a component of an external skin preparation, or it may be used at a desired concentration by concentration under reduced pressure or the like.
本発明に係る有効成分を皮膚外用剤に配合する場合、必須成分のナイアシンアミド及びタケノコ抽出物のほかに、通常、皮膚外用剤(外用医薬品、医薬部外品、化粧品)に用いられる成分、例えば油性成分、界面活性剤(合成系、天然物系)、乳化剤、乳化補助剤、保湿剤、消炎剤、増粘剤、防腐・殺菌剤、抗アクネ剤、細胞賦活剤、粉体成分、紫外線吸収剤、抗酸化剤、美白剤、色素、香料等を必要に応じて適宜配合することができる。 When the active ingredient according to the present invention is incorporated into a skin external preparation, in addition to the essential ingredients niacinamide and bamboo shoot extract, ingredients normally used in skin external preparations (topical drugs, quasi-drugs, cosmetics), such as Oil-based ingredients, surfactants (synthetic and natural), emulsifiers, emulsification aids, humectants, anti-inflammatory agents, thickeners, preservatives and disinfectants, anti-acne agents, cell activators, powder ingredients, ultraviolet absorption Agents, antioxidants, whitening agents, pigments, fragrances, etc. can be added as appropriate.
ここで、油性成分としては、例えば、オリーブ油、ホホバ油、ヒマシ油、大豆油、米油、米胚芽油、ヤシ油、パーム油、カカオ油、メドウフォーム油、シアバター、ティーツリー油、アボガド油、マカデミアナッツ油、ベルガモット油、ラベンダー油、バラ油、ベルガモット油、カミツレ油等の植物由来スクワラン等の植物由来の油脂類;ビタミンA油;ミンク油、タートル油等の動物由来の油脂類;ミツロウ、カルナウバロウ、ライスワックス、ラノリン等のロウ類;流動パラフィン、ワセリン、パラフィンワックス、スクワラン等の炭化水素類;ミリスチン酸、パルミチン酸、ステアリン酸、オレイン酸、イソステアリン酸、cis-11-エイコセン酸等の脂肪酸類;ラウリルアルコール、セタノール、パントテニルアルコール、ステアリルアルコール等の高級アルコール類;ミリスチン酸イソプロピル、パルミチン酸イソプロピル、オレイン酸ブチル、2-エチルヘキシルグリセライド、高級脂肪酸オクチルドデシル(ステアリン酸オクチルドデシル等)等の合成エステル類及び合成トリグリセライド類等が挙げられる。 Here, examples of oily ingredients include olive oil, jojoba oil, castor oil, soybean oil, rice oil, rice germ oil, coconut oil, palm oil, cacao oil, meadowfoam oil, shea butter, tea tree oil, and avocado oil. , plant-derived oils and fats such as plant-derived squalane such as macadamia nut oil, bergamot oil, lavender oil, rose oil, bergamot oil, and chamomile oil; vitamin A oil; animal-derived oils and fats such as mink oil and turtle oil; beeswax, Waxes such as carnauba wax, rice wax, and lanolin; Hydrocarbons such as liquid paraffin, petrolatum, paraffin wax, and squalane; Fatty acids such as myristic acid, palmitic acid, stearic acid, oleic acid, isostearic acid, and cis-11-eicosenoic acid. Higher alcohols such as lauryl alcohol, cetanol, pantothenyl alcohol, and stearyl alcohol; Synthesis of isopropyl myristate, isopropyl palmitate, butyl oleate, 2-ethylhexylglyceride, higher fatty acid octyldodecyl (octyldodecyl stearate, etc.) Examples include esters and synthetic triglycerides.
また、界面活性剤としては、例えばポリオキシエチレンアルキルエーテル、ポリオキシエチレン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、グリセリン脂肪酸エステル、ポリグリセリン脂肪酸エステル、ポリオキシエチレングリセリン脂肪酸エステル、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンソルビトール脂肪酸エステル等の非イオン界面活性剤;脂肪酸塩、アルキル硫酸塩、アルキルベンゼンスルホン酸塩、ポリオキシエチレンアルキルエーテル硫酸塩、ポリオキシエチレン脂肪アミン硫酸塩、ポリオキシエチレンアルキルフェニルエーテル硫酸塩、ポリオキシエチレンアルキルエーテル燐酸塩、α-スルホン化脂肪酸アルキルエステル塩、ポリオキシエチレンアルキルフェニルエーテル燐酸塩等のアニオン界面活性剤;第四級アンモニウム塩、第一級~第三級脂肪アミン塩、トリアルキルベンジルアンモニウム塩、アルキルピリジニウム塩、2-アルキル-1-アルキル-1-ヒドロキシエチルイミダゾリニウム塩、N、N-ジアルキルモルフォルニウム塩、ポリエチレンポリアミン脂肪酸アミド塩等のカチオン界面活性剤;N、N-ジメチル-N-アルキル-N-カルボキシメチルアンモニオベタイン、N、N、N-トリアルキル-N-アルキレンアンモニオカルボキシベタイン、N-アシルアミドプロピル-N′、N′-ジメチル-N′-β-ヒドロキシプロピルアンモニオスルホベタイン等の両性界面活性剤等を使用することができる。 Examples of surfactants include polyoxyethylene alkyl ether, polyoxyethylene fatty acid ester, polyoxyethylene sorbitan fatty acid ester, glycerin fatty acid ester, polyglycerin fatty acid ester, polyoxyethylene glycerin fatty acid ester, and polyoxyethylene hydrogenated castor oil. , nonionic surfactants such as polyoxyethylene sorbitol fatty acid esters; fatty acid salts, alkyl sulfates, alkylbenzene sulfonates, polyoxyethylene alkyl ether sulfates, polyoxyethylene fatty amine sulfates, polyoxyethylene alkyl phenyl ether sulfates Anionic surfactants such as salts, polyoxyethylene alkyl ether phosphates, α-sulfonated fatty acid alkyl ester salts, polyoxyethylene alkyl phenyl ether phosphates; quaternary ammonium salts, primary to tertiary fatty amine salts , trialkylbenzylammonium salts, alkylpyridinium salts, 2-alkyl-1-alkyl-1-hydroxyethylimidazolinium salts, N,N-dialkylmorphonium salts, polyethylene polyamine fatty acid amide salts, and other cationic surfactants; N,N-dimethyl-N-alkyl-N-carboxymethylammoniobetaine, N,N,N-trialkyl-N-alkyleneammoniocarboxybetaine, N-acylamidopropyl-N',N'-dimethyl-N Amphoteric surfactants such as '-β-hydroxypropylammoniosulfobetaine and the like can be used.
また、乳化剤及び/又は乳化助剤としては、酵素処理ステビア等のステビア誘導体、サポニン又はその誘導体、カゼイン又はその塩(ナトリウム等)、糖と蛋白質の複合体、ショ糖又はそのエステル、ラクトース、大豆由来の水溶性多糖、大豆由来蛋白質と多糖の複合体、ラノリン又はその誘導体、コレステロール、ステビア誘導体(ステビア酵素処理物等)、ケイ酸塩(アルミニウム、マグネシウム等)、炭酸塩(カルシウム、ナトリウム等)サポニン及びその誘導体、レシチン及びその誘導体(水素添加レシチン等)、乳酸菌醗酵米、乳酸菌醗酵発芽米、乳酸菌醗酵穀類(麦類、豆類、雑穀等)等を配合することもできる。 In addition, as emulsifiers and/or emulsification aids, stevia derivatives such as enzyme-treated stevia, saponin or its derivatives, casein or its salts (sodium, etc.), sugar and protein complexes, sucrose or its esters, lactose, soybean derived water-soluble polysaccharides, complexes of soybean-derived proteins and polysaccharides, lanolin or its derivatives, cholesterol, stevia derivatives (stevia enzyme-treated products, etc.), silicates (aluminum, magnesium, etc.), carbonates (calcium, sodium, etc.) Saponin and its derivatives, lecithin and its derivatives (hydrogenated lecithin, etc.), lactic acid bacteria-fermented rice, lactic acid bacteria-fermented germinated rice, lactic acid bacteria-fermented grains (wheat, beans, millet, etc.), etc. can also be blended.
また、保湿剤としては、例えば、グリセリン、プロピレングリコール、ジプロピレングリコール、1、3-ブチレングリコール、ポリエチレングリコール、ソルビトール、キシリトール、ピロリドンカルボン酸ナトリウム等があり、さらにトレハロース、ラフィノース等の糖類、ムコ多糖類(例えば、ヒアルロン酸及びその誘導体、ヒアルロン酸発酵液、コンドロイチン及びその誘導体、ヘパリン及びその誘導体等)、エラスチン及びその誘導体、コラーゲン及びその誘導体、コラーゲンペプチド、NMF関連物質、乳酸、尿素、高級脂肪酸オクチルドデシル、海藻抽出物、エストラジオール、各種アミノ酸及びそれらの誘導体が挙げられる。 Examples of moisturizing agents include glycerin, propylene glycol, dipropylene glycol, 1,3-butylene glycol, polyethylene glycol, sorbitol, xylitol, sodium pyrrolidone carboxylate, and saccharides such as trehalose and raffinose. Saccharides (e.g. hyaluronic acid and its derivatives, hyaluronic acid fermentation liquid, chondroitin and its derivatives, heparin and its derivatives, etc.), elastin and its derivatives, collagen and its derivatives, collagen peptides, NMF-related substances, lactic acid, urea, higher fatty acids Examples include octyldodecyl, seaweed extract, estradiol, various amino acids and their derivatives.
また、増粘剤としては、例えば、アルギン酸、寒天、カラギーナン、フコイダン等の褐藻、緑藻又は紅藻由来成分;ペクチン、アロエ多糖体等の多糖類;トラガントガム、ローカストビーンガム、キサンタンガム、グアーガム等のガム類;カルボキシメチルセルロース、ヒドロキシエチルセルロース、ヒドロキシプロピルセルロース等のセルロース誘導体;カルボシキビニルポリマー、アルキル変性カルボキシビニルポリマー、ポリビニルアルコール、ポリビニルピロリドン、アクリル酸・メタクリル酸共重合体等の合成高分子類;ヒアルロン酸及びその誘導体;ポリグルタミン酸及びその誘導体、ポリアクリル酸等が挙げられる。 Thickeners include, for example, ingredients derived from brown algae, green algae, or red algae such as alginic acid, agar, carrageenan, and fucoidan; polysaccharides such as pectin and aloe polysaccharide; gums such as tragacanth gum, locust bean gum, xanthan gum, and guar gum. Cellulose derivatives such as carboxymethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose; Synthetic polymers such as carboxyvinyl polymer, alkyl-modified carboxyvinyl polymer, polyvinyl alcohol, polyvinylpyrrolidone, acrylic acid/methacrylic acid copolymer; hyaluronic acid and derivatives thereof; examples include polyglutamic acid and derivatives thereof, polyacrylic acid, and the like.
また、消炎剤としては、アラントイン、グリチルリチン酸ジカリウム、グリチルリチン酸モノアンモニウム、β-グリチルレチン酸、グリチルレチン酸ステアリル、ε-アミノカプロン酸、d-カンフル、dl-カンフル、酸化亜鉛、パンテノール、ピリドキシン塩酸塩、及びリボフラビン又はその誘導体等がある。 In addition, anti-inflammatory agents include allantoin, dipotassium glycyrrhizinate, monoammonium glycyrrhizinate, β-glycyrrhetinic acid, stearyl glycyrrhetinate, ε-aminocaproic acid, d-camphor, dl-camphor, zinc oxide, panthenol, pyridoxine hydrochloride, and riboflavin or its derivatives.
また、防腐・殺菌剤としては、例えば尿素;安息香酸又はその塩、パラオキシ安息香酸メチル、パラオキシ安息香酸エチル、パラオキシ安息香酸プロピル、パラオキシ安息香酸ブチル等のパラオキシ安息香酸エステル類;フェノキシエタノール、ジクロロフェン、ヘキサクロロフェン、塩酸クロルヘキシジン、塩化ベンザルコニウム、サリチル酸、サリチル酸ナトリウム、ピリチオン亜鉛、塩化ベンザルコニウム、エタノール、ウンデシレン酸、フェノール類、臭化アルキルイソキノリニウム、レゾルシン、ジャマール(イミダゾデイニールウレア)、イソプロピルメチルフェノール、トリクロサン、トリクロロカルバニド、トリクロロヒドロキシジフェノールエーテル、ヒノキチオール、1、2-ペンタンジオール、プロパンジオール、濃ベンザルコニウム塩化物液50、ハッカ油、ユーカリ油等の精油類、樹皮乾留物、大根発酵液、サトウキビ、トウモロコシ等の植物由来のエタノール又は1、3-ブチレングリコール等がある。 Examples of preservatives and disinfectants include urea; benzoic acid or its salt, paraoxybenzoic acid esters such as methyl paraoxybenzoate, ethyl paraoxybenzoate, propyl paraoxybenzoate, and butyl paraoxybenzoate; phenoxyethanol, dichlorophen, Hexachlorophene, chlorhexidine hydrochloride, benzalkonium chloride, salicylic acid, sodium salicylate, zinc pyrithione, benzalkonium chloride, ethanol, undecylenic acid, phenols, alkylisoquinolinium bromide, resorcinol, jamal (imidazodeinyl urea), Isopropyl methylphenol, triclosan, trichlorocarbanide, trichlorohydroxydiphenol ether, hinokitiol, 1,2-pentanediol, propanediol, concentrated benzalkonium chloride solution 50, essential oils such as mentha oil, eucalyptus oil, bark dry distillate , fermented radish liquid, ethanol or 1,3-butylene glycol derived from plants such as sugar cane and corn.
また、細胞賦活剤としては、パントテニルアルコール、メントール、dl-メントール、及びγ-オリザノール等がある。 Furthermore, examples of cell activators include pantothenyl alcohol, menthol, dl-menthol, and γ-oryzanol.
また、抗アクネ剤としては、イオウ、サリチル酸又はその塩、感光素201号、ジカプリル酸ピリドキシン等がある。 Further, anti-acne agents include sulfur, salicylic acid or its salt, Photosensor No. 201, pyridoxine dicaprylate, and the like.
また、粉体成分しては、例えばセリサイト、酸化チタン、タルク、カオリン、ベントナイト、酸化亜鉛、炭酸マグネシウム、酸化マグネシウム、酸化ジルコニウム、硫酸バリウム、無水ケイ酸、雲母、ナイロンパウダー、ポリエチレンパウダー、シルクパウダー、セルロース系パウダー、穀類(米、麦、トウモロコシ、キビ等)のパウダー、豆類(大豆、アズキ等)のパウダー等がある。 Powder components include, for example, sericite, titanium oxide, talc, kaolin, bentonite, zinc oxide, magnesium carbonate, magnesium oxide, zirconium oxide, barium sulfate, silicic anhydride, mica, nylon powder, polyethylene powder, silk. There are powders, cellulose powders, grains (rice, wheat, corn, millet, etc.) powders, legumes (soybeans, adzuki beans, etc.) powders, etc.
また、紫外線吸収剤としては、例えばパラアミノ安息香酸エチル、パラジメチルアミノ安息香酸エチルヘキシル、サリチル酸アミル及びその誘導体、パラメトキシ桂皮酸2-エチルヘキシル、桂皮酸オクチル、オキシベンゾン、2、4-ジヒドロキシベンゾフェノン、2-ヒドロキシ-4-メトキシベンゾフェノン-5-スルホン酸塩、4-ターシャリーブチル-4-メトキシベンゾイルメタン、2-(2-ヒドロキシ-5-メチルフェニル)ベンゾトリアゾール、ウロカニン酸、ウロカニン酸エチル、アロエ抽出物等がある。 Examples of ultraviolet absorbers include ethyl para-aminobenzoate, ethylhexyl para-dimethylaminobenzoate, amyl salicylate and its derivatives, 2-ethylhexyl para-methoxycinnamate, octyl cinnamate, oxybenzone, 2,4-dihydroxybenzophenone, 2-hydroxy -4-methoxybenzophenone-5-sulfonate, 4-tert-butyl-4-methoxybenzoylmethane, 2-(2-hydroxy-5-methylphenyl)benzotriazole, urocanic acid, ethyl urocanate, aloe extract, etc. There is.
また、抗酸化剤としては、例えばブチルヒドロキシアニソール、ブチルヒドロキシトルエン、没食子酸プロピル、アスタキサンチン等のカロテノイド、ビタミンE及びその誘導体(例えば、トコフェロール酢酸エステル、トコフェロールニコチン酸エステル)、ビタミンA又はその誘導体(パルミチン酸レチノール等)等がある。 Antioxidants include, for example, carotenoids such as butylated hydroxyanisole, butylated hydroxytoluene, propyl gallate, astaxanthin, vitamin E and its derivatives (for example, tocopherol acetate, tocopherol nicotinate), vitamin A or its derivatives ( retinol palmitate, etc.).
また、美白剤として、コウジ酸又はその誘導体、アスコルビン酸又はその誘導体、ハイドロキノン又はその誘導体、エラグ酸及びその誘導体、レゾルシノール誘導体、4-メトキシサリチル酸カリウム塩、ビタミンE又はその誘導体、ニコチン酸又はその誘導体、マグノリグナン(5、5'-ジプロピル-ビフェニル-2、2’-ジオール)、ヒドロキシ安息香酸及びその誘導体、ビタミンE及びその誘導体、α-ヒドロキシ酸、AMP(アデノシンモノホスフェイト、アデノシン1リン酸)から選択される1以上のものが挙げられる。 In addition, as a whitening agent, kojic acid or its derivatives, ascorbic acid or its derivatives, hydroquinone or its derivatives, ellagic acid and its derivatives, resorcinol derivatives, 4-methoxysalicylic acid potassium salt, vitamin E or its derivatives, nicotinic acid or its derivatives. , magnolignan (5,5'-dipropyl-biphenyl-2,2'-diol), hydroxybenzoic acid and its derivatives, vitamin E and its derivatives, α-hydroxy acid, AMP (adenosine monophosphate, adenosine monophosphate) ) may be one or more selected from.
なお、コウジ酸誘導体としては、例えば、コウジ酸モノブチレート、コウジ酸モノカプレート、コウジ酸モノパルミテート、コウジ酸ジブチレート等のコウジ酸エステル類、コウジ酸エーテル類、コウジ酸グルコシド等のコウジ酸糖誘導体等が、アスコルビン酸誘導体としては、例えばL-アスコルビン酸-2-リン酸エステルナトリウム、L-アスコルビン酸-2-リン酸エステルマグネシウム、L-アスコルビン酸-2-硫酸エステルナトリウム、L-アスコルビン酸-2-硫酸エステルマグネシウム等のアスコルビン酸エステル塩類、L-アスコルビン酸-2-グルコシド(2-O-α-D-グルコピラノシル-L-アスコルビン酸)、L-アスコルビン酸-5-グルコシド(5-O-α-D-グルコピラノシル-L-アスコルビン酸)等のアスコルビン酸糖誘導体、それらアスコルビン酸糖誘導体の6位アシル化物(アシル基は、ヘキサノイル基、オクタノイル基、デカノイル基等)、L-アスコルビン酸テトライソパルミチン酸エステル、L-アスコルビン酸テトララウリン酸エステル等のL-アスコルビン酸テトラ脂肪酸エステル類、3-O-エチルアスコルビン酸、L-アスコルビン酸-2-リン酸-6-O-パルミテートナトリウム等が、ハイドロキノン誘導体としては、アルブチン(ハイドロキノン-β-D-グルコピラノシド)、α-アルブチン(ハイドロキノン-α-D-グルコピラノシド)等が、レゾルシノール誘導体としては、例えば4-n-ブチルレゾルシノール、4-イソアミルレゾルシノール等が、2,5-ジヒドロキシ安息香酸誘導体としては、例えば2,5-ジアセトキシ安息香酸、2-アセトキシ-5-ヒドロキシ安息香酸、2-ヒドロキシ-5-プロピオニルオキシ安息香酸等が、ニコチン酸誘導体としては、例えばニコチン酸アミド、ニコチン酸ベンジル等が、ビタミンE誘導体としては、例えばビタミンEニコチネート、ビタミンEリノレート等が、α-ヒドロキシ酸としては、例えば乳酸、リンゴ酸、コハク酸、クエン酸、α-ヒドロキシオクタン酸等がある。 Examples of kojic acid derivatives include kojic acid esters such as kojic acid monobutyrate, kojic acid monocaprate, kojic acid monopalmitate, and kojic acid dibutyrate, kojic acid sugar derivatives such as kojic acid ethers, and kojic acid glucoside. Examples of ascorbic acid derivatives include sodium L-ascorbic acid 2-phosphate, magnesium L-ascorbic acid 2-phosphate, sodium L-ascorbic acid 2-sulfate, and sodium L-ascorbic acid 2-phosphate. Ascorbic acid ester salts such as magnesium 2-sulfate ester, L-ascorbic acid-2-glucoside (2-O-α-D-glucopyranosyl-L-ascorbic acid), L-ascorbic acid-5-glucoside (5-O- Ascorbic acid sugar derivatives such as α-D-glucopyranosyl-L-ascorbic acid), 6-acylated products of these ascorbic acid sugar derivatives (acyl group is hexanoyl group, octanoyl group, decanoyl group, etc.), L-ascorbic acid tetraiso L-ascorbic acid tetra fatty acid esters such as palmitic acid ester, L-ascorbic acid tetralauric ester, 3-O-ethyl ascorbic acid, sodium L-ascorbic acid-2-phosphate-6-O-palmitate, etc. , Hydroquinone derivatives include arbutin (hydroquinone-β-D-glucopyranoside), α-arbutin (hydroquinone-α-D-glucopyranoside), and resorcinol derivatives include 4-n-butylresorcinol, 4-isoamylresorcinol, etc. However, examples of 2,5-dihydroxybenzoic acid derivatives include 2,5-diacetoxybenzoic acid, 2-acetoxy-5-hydroxybenzoic acid, and 2-hydroxy-5-propionyloxybenzoic acid, and examples of nicotinic acid derivatives include Examples of vitamin E derivatives include vitamin E nicotinate and vitamin E linoleate; examples of α-hydroxy acids include lactic acid, malic acid, succinic acid, citric acid, α- Examples include hydroxyoctanoic acid.
本発明においては、ナイアシンアミド及びタケノコの抽出物と、グリチルリチン酸ジカリウム、アスコルビン酸又はその誘導体、コウジ酸又はその誘導体、トラネキサム酸又はその誘導体、アルブチン、ビタミンE又はその誘導体等と併用することで、さらに、シワ改善や美白効果等の相乗効果を発揮することも示唆される。 In the present invention, by using niacinamide and bamboo shoot extract in combination with dipotassium glycyrrhizinate, ascorbic acid or its derivatives, kojic acid or its derivatives, tranexamic acid or its derivatives, arbutin, vitamin E or its derivatives, etc. Furthermore, it is also suggested that it exhibits synergistic effects such as wrinkle improvement and whitening effects.
本発明に係るナイアシンアミドとタケノコ抽出物の組み合わせを含む皮膚外用剤(化粧品、医薬部外品、外用医薬品を含む)の適用部位としては、頭皮を含む皮膚全般が挙げられ、特に制限はない。従って、剤形としては、例えば、乳液、クリーム、ローション、エッセンス、パック、口紅、ファンデーション、リクイドファンデーション、メイクアッププレスパウダー、ほほ紅、白粉、洗顔料、ボディシャンプー、石けん、マスク用製剤、及び浴剤等が挙げられるが、本発明はそれらに限定されるものではない。 The skin external preparation (including cosmetics, quasi-drugs, and external drugs) containing the combination of niacinamide and bamboo shoot extract according to the present invention can be applied to the skin in general, including the scalp, and is not particularly limited. Therefore, the dosage forms include milky lotions, creams, lotions, essences, packs, lipsticks, foundations, liquid foundations, makeup press powders, blushers, whitening powders, facial cleansers, body shampoos, soaps, mask preparations, and baths. agents, but the present invention is not limited thereto.
次に、製造例、処方例、実施例及び試験例によって本発明をさらに具体的に説明するが、本発明はそれらに限定されるものではない。なお、以下において、部はすべて重量部を、また%はすべて重量%を意味する。 Next, the present invention will be explained in more detail with reference to production examples, formulation examples, working examples, and test examples, but the present invention is not limited thereto. In addition, in the following, all parts mean parts by weight, and all percentages mean weight %.
製造例1.タケノコの皮抽出物(1)
モウソウチクのタケノコの皮の乾燥粉砕物100gに精製水1000g及び乳酸0.92gを加え、40℃で4時間抽出を行い、その抽出液を濾過し、淡褐色のタケノコの皮の抽出物溶液532gを得た(固形分濃度0.6%)。
Manufacturing example 1. Bamboo shoot skin extract (1)
Add 1000 g of purified water and 0.92 g of lactic acid to 100 g of dried pulverized bamboo shoot skin of Mosouchiku, perform extraction at 40°C for 4 hours, filter the extract, and add 532 g of light brown bamboo shoot skin extract solution. (solid content concentration 0.6%).
製造例2.タケノコの皮抽出物(2)
モウソウチクのタケノコの皮の乾燥粉砕物100gに精製水1000gを加え、40℃で4時間抽出を行い、その抽出液を濾過し、淡褐色のタケノコの皮の抽出物溶液521gを得た(固形分濃度0.5%)。
Production example 2. Bamboo shoot skin extract (2)
1000 g of purified water was added to 100 g of dried and crushed bamboo shoot peels of Mosouchiku, and extraction was performed at 40°C for 4 hours. The extract was filtered to obtain 521 g of a pale brown bamboo shoot skin extract solution (solid content concentration 0.5%).
製造例3.タケノコの皮抽出物(3)
製造例1において、モウソウチクに代えてマダケ(Phyllostachys bambusoides)のタケノコの皮の乾燥粉砕物100gを使用する他は、製造例2と同様の工程にて、淡褐色透明のマダケ抽出物640g(固形分濃度:0.6%)を得た。
Production example 3. Bamboo shoot skin extract (3)
In Production Example 1, 640 g of light brown transparent Madake extract (solid content Concentration: 0.6%) was obtained.
試験例1.線維芽細胞ヒアルロン酸合成促進評価
ナイアシンアミドとタケノコ抽出物の有効性として以下の方法により、ヒアルロン酸合成促進効果を評価した。まず、ヒト真皮由来線維芽細胞NB1RGBを、0.5%NCS含有イーグル最少必須培地を入れた96穴マイクロプレートに1×104個/穴播種し、37℃,5.0%CO2の条件下に1日間プレ培養した後、本発明の試料溶液として、ナイアシンアミド(1mM)及び製造例1の抽出物を培地に添加し、同条件でさらに5日間培養した。ここで、製造例1の抽出物の濃度は、培地量に対して、溶液としての終濃度が0.5%になるように添加した本発明試料1と、溶液としての終濃度が1.0%になるように添加した本発明試料2を設定した。また、本発明試料に代えて比較試料として、ナイアシンアミド(1mM)のみからなる比較試料1と製造例1の抽出物のみからなる比較試料2,3についても、同様に試験を行った。ここで、比較試料における製造例1の抽出物の濃度は、培地量に対して、溶液としての終濃度が0.5%になるように添加した比較試料2と、溶液としての終濃度が1.0%になるように添加した比較試料3を設定した。上述のように、本発明試料1,2、比較試料1~3をそれぞれ添加した培地で細胞を培養後、それぞれのウェルから上清を回収し、ヒアルロン酸測定キット(Quantikine(登録商標) ELISA Hyaluronan Immunoassay、R&D SYSTEMS、USA)を用いて上清中のヒアルロン酸量を定量した。なお、上記本発明試料の代わりにPBS(-)を添加した区をコントロールとし、コントロール区のヒアルロン酸合成量に対する各試料添加区のヒアルロン酸合成量の相対値を算出し、ヒアルロン酸合成促進効果(%)を求めた。
Test example 1. Fibroblast Cell Hyaluronic Acid Synthesis Promotion Evaluation As for the effectiveness of niacinamide and bamboo shoot extract, the hyaluronic acid synthesis promoting effect was evaluated by the following method. First, human dermis-derived fibroblasts NB1RGB were seeded at 1× 10 cells/well in a 96-well microplate containing Eagle's minimum essential medium containing 0.5% NCS, and the cells were incubated at 37°C and 5.0% CO2. After pre-cultured for 1 day, niacinamide (1 mM) and the extract of Production Example 1 were added to the medium as a sample solution of the present invention, and cultured under the same conditions for an additional 5 days. Here, the concentration of the extract of Production Example 1 is as follows: Sample 1 of the present invention, which was added so that the final concentration as a solution was 0.5% based on the amount of the medium, and Sample 1 of the present invention, which was added so that the final concentration as a solution was 1.0%. A sample 2 of the present invention was set in which the amount of the compound was added so as to be %. In addition, as comparative samples instead of the present invention samples, Comparative Sample 1 consisting only of niacinamide (1 mM) and Comparative Samples 2 and 3 consisting only of the extract of Production Example 1 were also tested in the same manner. Here, the concentration of the extract of Production Example 1 in the comparative sample is as follows: Comparative Sample 2, which was added so that the final concentration as a solution was 0.5% based on the amount of the medium, and Comparative Sample 2, which was added so that the final concentration as a solution was 1%. Comparative sample 3 was set in which the amount was added to .0%. As described above, after culturing cells in a medium supplemented with samples 1 and 2 of the present invention and comparative samples 1 to 3, the supernatant was collected from each well, and a hyaluronic acid measurement kit (Quantikine (registered trademark) ELISA Hyaluronan The amount of hyaluronic acid in the supernatant was quantified using Immunoassay, R&D SYSTEMS, USA). In addition, a group in which PBS (-) was added instead of the above-mentioned sample of the present invention was used as a control, and the relative value of the amount of hyaluronic acid synthesized in each sample addition group to the amount of hyaluronic acid synthesized in the control group was calculated, and the effect of promoting hyaluronic acid synthesis was calculated. (%) was calculated.
試験例1の結果を図1,2に示す。まず、図1に示す通り、本発明試料1「ナイアシンアミド1mM及び製造例1の抽出物(0.5%)」は比較試料1,2と比較して顕著なヒアルロン酸合成促進の相乗効果を示した。製造例1の抽出物の濃度が0.5%場合、ナイアシンアミドと併用することで、製造例1の抽出物(0.5%)とナイアシンアミドのそれぞれ単独での値を相加した効果と比較して約1.7倍高い相乗効果が確認された。また、図2に示す通り、本発明試料2「ナイアシンアミド1mM及び製造例1の抽出物(1.0%)」は比較試料1,3と比較して顕著なヒアルロン酸合成促進の相乗効果を示した。製造例1の抽出物の濃度が1.0%場合、ナイアシンアミドと併用することで、製造例1の抽出物(1.0%)とナイアシンアミドのそれぞれ単独での値を相加した効果と比較して約1.6倍高い相乗効果が確認された。 The results of Test Example 1 are shown in Figures 1 and 2. First, as shown in Figure 1, sample 1 of the present invention "niacinamide 1mM and the extract of Production Example 1 (0.5%)" has a remarkable synergistic effect of promoting hyaluronic acid synthesis compared to comparative samples 1 and 2. Indicated. When the concentration of the extract of Production Example 1 is 0.5%, by using it together with niacinamide, the effect is equal to the additive effect of the extract of Production Example 1 (0.5%) and niacinamide, respectively. In comparison, a synergistic effect that was approximately 1.7 times higher was confirmed. In addition, as shown in Figure 2, sample 2 of the present invention "niacinamide 1mM and the extract of Production Example 1 (1.0%)" has a synergistic effect of promoting hyaluronic acid synthesis that is remarkable compared to comparative samples 1 and 3. Indicated. When the concentration of the extract of Production Example 1 is 1.0%, by using it together with niacinamide, the effect is equal to the additive effect of the extract of Production Example 1 (1.0%) and niacinamide, respectively. In comparison, a synergistic effect that was approximately 1.6 times higher was confirmed.
処方例1.化粧水
[成分] 部
ユーカリ油 0.2
ポリオキシエチレン(5.5)セチルアルコール 5.0
ナイアシンアミド 5.0
製造例1の抽出物 0.5
トコフェロール酢酸エステル 0.02
グリチルリチン酸ジカリウム 0.5
グリチルリチン酸モノアンモニウム 0.5
グリチルリチン酸ステアリル 0.05
イソプロピルメチルフェノール 0.1
アライントイン 0.1
D-パントテニルアルコール 0.1
サリチル酸 0.5
尿素 5.0
l-メントール 0.9
dl-メントール 0.2
1,3-ブチレングリコール 5.0
クエン酸ナトリウム 0.2
メチルパラベン 0.1
ヒノキチオール 0.003
感光素201号 0.002
精製水 全量が100部となる量
Prescription example 1. Lotion [Ingredients] Part Eucalyptus oil 0.2
Polyoxyethylene (5.5) Cetyl Alcohol 5.0
Niacinamide 5.0
Extract of Production Example 1 0.5
Tocopherol acetate 0.02
Dipotassium glycyrrhizinate 0.5
Monoammonium glycyrrhizinate 0.5
Stearyl glycyrrhizinate 0.05
Isopropylmethylphenol 0.1
Align in 0.1
D-pantothenyl alcohol 0.1
Salicylic acid 0.5
Urea 5.0
l-menthol 0.9
dl-menthol 0.2
1,3-butylene glycol 5.0
Sodium citrate 0.2
Methylparaben 0.1
Hinokitiol 0.003
Photosensitive element No. 201 0.002
Purified water Amount that makes the total amount 100 parts
処方例2.化粧水
[成分] 部
カプリル酸グリセリル 3.0
ラウリン酸ポリグリセリル-10 3.0
セタノール 2.0
ベヘニルアルコール 2.0
メチルパラベン 0.1
ナイアシンアミド 5.0
製造例1の抽出物 1.0
アスコルビン酸 3.0
グリチルリチン酸 0.5
β-グリチルレチン酸 0.05
トコフェロールニコチン酸エステル 0.1
レゾルシン 0.1
酸化亜鉛 2.0
dl-カンフル 0.5
グリセリン 2.0
1,3-ブチレングリコール 5.0
水酸化カリウム 0.5
精製水 全量が100部となる量
Prescription example 2. Lotion [Ingredients] Part Glyceryl caprylate 3.0
Polyglyceryl laurate-10 3.0
Setanol 2.0
Behenyl alcohol 2.0
Methylparaben 0.1
Niacinamide 5.0
Extract of Production Example 1 1.0
Ascorbic acid 3.0
Glycyrrhizic acid 0.5
β-Glycyrrhetinic acid 0.05
Tocopherol nicotinic acid ester 0.1
Resorcinol 0.1
Zinc oxide 2.0
dl-camphor 0.5
Glycerin 2.0
1,3-butylene glycol 5.0
Potassium hydroxide 0.5
Purified water Amount that makes the total amount 100 parts
処方例3.化粧水
[成分] 部
ホホバ油 1.0
ポリオキシエチレン(5.5)セチルアルコール 5.0
メチルパラベン 0.1
ナイアシンアミド 3.0
アスコルビン酸グルコシド 2.0
トラネキサム酸 2.0
ε-アミノカプロン酸 0.1
イオウ 0.2
エストラジオール 0.1
製造例1の抽出物 1.0
グリセリン 5.0
1,3-ブチレングリコール 5.0
クエン酸ナトリウム 0.2
メタ重亜硫酸ナトリウム 0.2
d-カンフル 0.1
精製水 全量が100部となる量
Prescription example 3. Lotion [Ingredients] Part Jojoba oil 1.0
Polyoxyethylene (5.5) Cetyl Alcohol 5.0
Methylparaben 0.1
Niacinamide 3.0
Ascorbic acid glucoside 2.0
Tranexamic acid 2.0
ε-Aminocaproic acid 0.1
Sulfur 0.2
Estradiol 0.1
Extract of Production Example 1 1.0
Glycerin 5.0
1,3-butylene glycol 5.0
Sodium citrate 0.2
Sodium metabisulfite 0.2
d-camphor 0.1
Purified water Amount that makes the total amount 100 parts
処方例4.化粧水
処方例3の成分中、製造例1の抽出物1.0部に代えて製造例2の抽出物1.0部を用いるほかは処方例3を同様にして化粧水を得た。
Prescription example 4. Lotion A lotion was obtained in the same manner as in Formulation Example 3, except that 1.0 part of the extract of Production Example 2 was used in place of 1.0 part of the extract of Production Example 1 among the ingredients of Formulation Example 3.
処方例5.化粧水
処方例3の成分中、製造例1の抽出物1.0部に代えて製造例3の抽出物1.0部を用いるほかは処方例3を同様にして化粧水を得た。
Prescription example 5. Lotion A lotion was obtained in the same manner as in Formulation Example 3, except that 1.0 part of the extract of Production Example 3 was used in place of 1.0 part of the extract of Production Example 1 among the ingredients of Formulation Example 3.
処方例6.乳液
[成分] 部
スクワラン 5.0
シクロペンタンシロキサン 1.0
ヘキサラン 3.0
イソステアリン酸ヘキシルデシル 1.0
トリ(カプリル酸/カプリン酸)グリセリル 1.0
ラウリン酸ポリグリセリル-10 5.0
イソステアリン酸ポリグリセリル-10 5.0
ジパルミチン酸アスコルビル 15.0
水添大豆レシチン 1.5
ナイアシンアミド 5.0
製造例1の抽出物 1.0
アスコルビン酸グルコシド 2.0
アルブチン 3.0
水酸化カリウム 0.5
グリセリン 3.0
1,3-ブチレングリコール 2.0
カルボキシメチルセルロース 0.3
キサンタンガム 0.2
シロキクラゲ多糖体 0.2
ヒアルロン酸ナトリウム 0.01
トコフェロール酢酸エステル 0.3
トコフェロールニコチン酸エステル 0.1
グリチルリチン酸 0.1
グリチルリチン酸ジカリウム 0.1
イソプロピルメチルフェノール 0.1
水溶性コラーゲン 1.0
加水分解コラーゲン 1.0
ヒアルロン酸ナトリウム 1.0
精製水 全量が100部となる量
Prescription example 6. Emulsion [Ingredients] Part Squalane 5.0
Cyclopentane siloxane 1.0
Hexalan 3.0
Hexyldecyl isostearate 1.0
Caprylic/capric triglyceride 1.0
Polyglyceryl laurate-10 5.0
Polyglyceryl-10 isostearate 5.0
Ascorbyl dipalmitate 15.0
Hydrogenated soy lecithin 1.5
Niacinamide 5.0
Extract of Production Example 1 1.0
Ascorbic acid glucoside 2.0
Arbutin 3.0
Potassium hydroxide 0.5
Glycerin 3.0
1,3-butylene glycol 2.0
Carboxymethyl cellulose 0.3
Xanthan gum 0.2
White fungus polysaccharide 0.2
Sodium hyaluronate 0.01
Tocopherol acetate 0.3
Tocopherol nicotinic acid ester 0.1
Glycyrrhizic acid 0.1
Dipotassium glycyrrhizinate 0.1
Isopropylmethylphenol 0.1
Water-soluble collagen 1.0
Hydrolyzed collagen 1.0
Sodium hyaluronate 1.0
Purified water Amount that makes the total amount 100 parts
処方例7.乳液
処方例6の成分中、アスコルビン酸グルコシド2.0部に代えてリン酸L-アスコルビルマグネシウム2.0部を用いるほかは処方例6を同様にして乳液を得た。
Prescription example 7. Emulsion A milky lotion was obtained in the same manner as in Prescription Example 6, except that 2.0 parts of L-ascorbyl magnesium phosphate was used in place of 2.0 parts of ascorbic acid glucoside.
処方例8.乳液
処方例6の成分中、アスコルビン酸グルコシド2.0部に代えて3-O-エチルアスコルビン酸2.0部を用いるほかは処方例6と同様にして乳液を得た。
Prescription example 8. Emulsion A milky lotion was obtained in the same manner as in Formulation Example 6 except that 2.0 parts of 3-O-ethyl ascorbic acid was used in place of 2.0 parts of ascorbic acid glucoside among the components of Formulation Example 6.
処方例9.クリーム
[成分] 部
オリーブ油 5.0
ホホバ油 5.0
スクワラン 5.0
イソステアリン酸ヘキシルデシル 5.0
ラウロイルグルタミン酸ジ(オクチルドデシル/フィトステリル/ベヘニル) 5.0
カプリル酸グリセリル 1.0
ステアリン酸グリセリル 1.0
イソステアリルグリセリル 3.0
ナイアシンアミド 5.0
製造例2の抽出物 1.0
γ-オリザノール 0.1
ベヘニルアルコール 2.0
パルミチン酸 2.5
D-パントテニルアルコール 3.0
アラントイン 0.1
リボフラビン 0.01
レゾルシン 0.1
塩化ベンザルコニウム 0.05
尿素 3.0
β-グリチルレチン酸 0.1
グリチルレチン酸ステアリル 0.1
グリチルリチン酸アンモニウム 0.1
乳酸菌発酵米 2.0
水添レシチン 0.5
水添リゾレシチン 0.5
油溶性オタネニンジンエキス 2.0
キサンタンガム 1.0
酸化亜鉛 0.5
dl-カンフル 0.3
l-メントール 0.5
精製水 全量が100部となる量
Prescription example 9. Cream [Ingredients] Part Olive oil 5.0
Jojoba oil 5.0
Squalane 5.0
Hexyldecyl isostearate 5.0
Di(octyldodecyl/phytosteryl/behenyl) lauroylglutamate 5.0
Glyceryl caprylate 1.0
Glyceryl stearate 1.0
Isostearylglyceryl 3.0
Niacinamide 5.0
Extract of Production Example 2 1.0
γ-oryzanol 0.1
Behenyl alcohol 2.0
Palmitic acid 2.5
D-pantothenyl alcohol 3.0
Allantoin 0.1
Riboflavin 0.01
Resorcinol 0.1
Benzalkonium chloride 0.05
Urea 3.0
β-Glycyrrhetinic acid 0.1
Stearyl glycyrrhetinate 0.1
Ammonium glycyrrhizinate 0.1
Lactic acid bacteria fermented rice 2.0
Hydrogenated lecithin 0.5
Hydrogenated lysolecithin 0.5
Oil-soluble Panax ginseng extract 2.0
Xanthan gum 1.0
Zinc oxide 0.5
dl-camphor 0.3
l-menthol 0.5
Purified water Amount that makes the total amount 100 parts
処方例10.パック
[成分] 部
ジプロピレングリコール 5.0
ポリオキシエチレン(60)硬化ヒマシ油 5.0
セタノール 3.0
ベヘニルアルコール 3.0
アラントイン 0.1
グリチルリチン酸ジカリウム 0.1
グリチルリチン酸アンモニウム 0.1
β-グリチルレチン酸 0.1
グリチルレチン酸ステアリル 0.1
サリチル酸 0.1
トコフェロール酢酸エステル 0.5
トコフェロールニコチン酸エステル 0.1
D-パントテニルアルコール 0.3
レゾルシン 0.1
イオウ 2.0
エストラジオール 0.002
ナイアシンアミド 5.0
製造例1の抽出物 1.0
キサンタンガム 2.0
ミリスチン酸ポリグリセリル-6 1.0
ココイルグルタミン酸カリウム 1.0
水添レシチン 3.0
水酸化レシチン 3.0
精製水 全量が100部となる量
Prescription example 10. Pack [Ingredients] Part Dipropylene glycol 5.0
Polyoxyethylene (60) hydrogenated castor oil 5.0
Setanol 3.0
Behenyl alcohol 3.0
Allantoin 0.1
Dipotassium glycyrrhizinate 0.1
Ammonium glycyrrhizinate 0.1
β-Glycyrrhetinic acid 0.1
Stearyl glycyrrhetinate 0.1
Salicylic acid 0.1
Tocopherol acetate 0.5
Tocopherol nicotinic acid ester 0.1
D-pantothenyl alcohol 0.3
Resorcinol 0.1
Sulfur 2.0
Estradiol 0.002
Niacinamide 5.0
Extract of Production Example 1 1.0
Xanthan gum 2.0
Polyglyceryl-6 myristate 1.0
Potassium cocoyl glutamate 1.0
Hydrogenated lecithin 3.0
Hydroxylated lecithin 3.0
Purified water Amount that makes the total amount 100 parts
処方例11.ヘアシャンプー
[成分] 部
ラウレス硫酸ナトリウム 10.0
モノステアリン酸グリセリル 1.0
ヤシ油脂肪酸ジエタノールアミド 2.0
ポリオキシエチレン(40)硬化ヒマシ油 0.5
塩化ベンザルコニウム 1.0
ステアリルアルコール 2.0
ベヘニルアルコール 2.0
ジメチコン 3.0
ナイアシンアミド 1.0
製造例1の抽出物 1.0
アラントイン 0.1
グリチルリチン酸ジカリウム 0.1
サリチル酸 0.1
サリチル酸ナトリウム 0.1
トコフェロール酢酸エステル 0.1
ピリチオン亜鉛 0.3
安息香酸 0.2
トリクロサン 0.2
クエン酸 0.1
プロピレングリコール 2.0
精製水 全量が100部となる量
Prescription example 11. Hair shampoo [Ingredients] Part Sodium laureth sulfate 10.0
Glyceryl monostearate 1.0
Coconut oil fatty acid diethanolamide 2.0
Polyoxyethylene (40) hydrogenated castor oil 0.5
Benzalkonium chloride 1.0
Stearyl alcohol 2.0
Behenyl alcohol 2.0
Dimethicone 3.0
Niacinamide 1.0
Extract of Production Example 1 1.0
Allantoin 0.1
Dipotassium glycyrrhizinate 0.1
Salicylic acid 0.1
Sodium salicylate 0.1
Tocopherol acetate 0.1
Pyrithione zinc 0.3
Benzoic acid 0.2
Triclosan 0.2
Citric acid 0.1
Propylene glycol 2.0
Purified water Amount that makes the total amount 100 parts
処方例12.ヘアコンディショナー
[成分] 部
ポリオキシエチレン(10)硬化ヒマシ油 1.0
塩化ジステアリルジメチルアンモニウム 1.5
塩化ステアリルトリメチルアンモニウム 2.0
2-エチルヘキサン酸グリセリル 1.0
塩化ベンザルコニウム 1.0
セタノール 3.0
ステアリルアルコール 1.0
ナイアシンアミド 1.0
製造例2の抽出物 1.0
アラントイン 0.1
イソプロピルメチルフェノール 0.1
グリチルリチン酸ジカリウム 0.1
サリチル酸 0.1
イオウ 0.5
臭化アルキルイソキノリニウム液(75%) 0.06
ピリチオン亜鉛 0.3
メチルパラベン 0.1
トリクロサン 0.2
レゾルシン 0.1
精製水 全量が100部となる量
Prescription example 12. Hair conditioner [Ingredients] Part Polyoxyethylene (10) Hydrogenated castor oil 1.0
Distearyldimethylammonium chloride 1.5
Stearyltrimethylammonium chloride 2.0
Glyceryl 2-ethylhexanoate 1.0
Benzalkonium chloride 1.0
Setanol 3.0
Stearyl alcohol 1.0
Niacinamide 1.0
Extract of Production Example 2 1.0
Allantoin 0.1
Isopropylmethylphenol 0.1
Dipotassium glycyrrhizinate 0.1
Salicylic acid 0.1
Sulfur 0.5
Alkylisoquinolinium bromide liquid (75%) 0.06
Pyrithione zinc 0.3
Methylparaben 0.1
Triclosan 0.2
Resorcinol 0.1
Purified water Amount that makes the total amount 100 parts
処方例13.洗浄用化粧料
[成分] 部
ココイルグリシンカリウム 5.0
グリセリン 10.0
カプリル酸グリセリル 1.0
ラウロイルアスパラギン酸ナトリウム 10.0
ナイアシンアミド 1.0
製造例1の抽出物 1.0
セタノール 3.0
ミリスチルアルコール 3.0
イソプロピルメチルアルコール 0.1
アラントイン 0.1
イオウ 0.5
グリチルリチン酸 0.1
グリチルリチン酸ジカリウム 0.1
グリチルリチン酸モノアンモニウム 0.1
β-グリチルレチン酸 0.05
グリチルレチン酸ステアリル 0.1
サリチル酸 0.2
トコフェロール酢酸エステル 0.2
トリクロサン 0.1
トリクロロカルバニド 0.5
トリクロロヒドロキシジフェニルエーテル 0.2
濃ベンザルコニウム塩化物液50 0.2
ベンザルコニウム塩化物 0.1
精製水 全量が100部となる量
Prescription example 13. Cleansing cosmetics [Ingredients] Part Cocoylglycine potassium 5.0
Glycerin 10.0
Glyceryl caprylate 1.0
Sodium lauroyl aspartate 10.0
Niacinamide 1.0
Extract of Production Example 1 1.0
Setanol 3.0
Myristyl alcohol 3.0
Isopropyl methyl alcohol 0.1
Allantoin 0.1
Sulfur 0.5
Glycyrrhizic acid 0.1
Dipotassium glycyrrhizinate 0.1
Monoammonium glycyrrhizinate 0.1
β-Glycyrrhetinic acid 0.05
Stearyl glycyrrhetinate 0.1
Salicylic acid 0.2
Tocopherol acetate 0.2
Triclosan 0.1
Trichlorocarbanide 0.5
Trichlorohydroxydiphenyl ether 0.2
Concentrated benzalkonium chloride solution 50 0.2
Benzalkonium chloride 0.1
Purified water Amount that makes the total amount 100 parts
処方例14.シートマスク
不織布に下記の成分を含浸させてシートマスクを得る。
[成分] 部
グリセリン 3.0
1、3-ブチレングリコール 2.0
L-アスコルビン酸 2-グルコシド 2.0
メチルパラベン 0.2
クエン酸 0.1
クエン酸ナトリウム 0.3
キサンタンガム 1.0
水溶性コラーゲン 1.0
ヒアルロン酸ナトリウム 1.0
アマモ抽出物 1.0
ナイアシンアミド 5.0
製造例1の抽出物 1.0
水酸化カリウム 適量
精製水 全量が100部となる量
Prescription example 14. Sheet mask A sheet mask is obtained by impregnating a nonwoven fabric with the following ingredients.
[Ingredients] Part Glycerin 3.0
1,3-butylene glycol 2.0
L-ascorbic acid 2-glucoside 2.0
Methylparaben 0.2
Citric acid 0.1
Sodium citrate 0.3
Xanthan gum 1.0
Water-soluble collagen 1.0
Sodium hyaluronate 1.0
Eelgrass extract 1.0
Niacinamide 5.0
Extract of Production Example 1 1.0
Potassium hydroxide (appropriate amount) Purified water (amount to make 100 parts)
処方例15.美容液
[成分] 部
エタノール 2.0
グリセリン 5.0
1、3-ブチレングリコール 5.0
メチルパラベン 0.1
ヒアルロン酸加水分解物 1.0
乳酸菌培養物 1.0
ナイアシンアミド 3.0
製造例1の抽出物 1.0
クエン酸 0.3
クエン酸ナトリウム 0.6
精製水 全量が100部となる量
Prescription example 15. Beauty serum [Ingredients] Part Ethanol 2.0
Glycerin 5.0
1,3-butylene glycol 5.0
Methylparaben 0.1
Hyaluronic acid hydrolyzate 1.0
Lactic acid bacteria culture 1.0
Niacinamide 3.0
Extract of Production Example 1 1.0
Citric acid 0.3
Sodium citrate 0.6
Purified water Amount that makes the total amount 100 parts
処方例16.シワ改善用クリーム
[成分] 部
オリーブ油 5.0
スクワラン 5.0
ホホバ油 5.0
ホホバワックス 1.0
シアバター 2.0
べヘニルアルコール 1.0
ステアリルアルコール 1.5
キャンデリラワックス 0.5
ナイアシンアミド 5.0
乳酸菌発酵米 3.0
製造例1の抽出物 1.0
水添レシチン 2.0
カタメンキリンサイ抽出物 2.0
カルボキシビニルポリマー 0.3
アルギン酸ナトリウム 0.2
グリセリン 4.0
水酸化カリウム 適 量
精製水 全量が100部となる量
Prescription example 16. Wrinkle improvement cream [Ingredients] Part Olive oil 5.0
Squalane 5.0
Jojoba oil 5.0
Jojoba wax 1.0
shea butter 2.0
Behenyl alcohol 1.0
Stearyl alcohol 1.5
Candelilla wax 0.5
Niacinamide 5.0
Lactic acid bacteria fermented rice 3.0
Extract of Production Example 1 1.0
Hydrogenated lecithin 2.0
Katamen Kirin Rhino Extract 2.0
Carboxyvinyl polymer 0.3
Sodium alginate 0.2
Glycerin 4.0
Potassium hydroxide Appropriate amount Purified water Amount to make the total amount 100 parts
処方例17.シワ改善用クリーム
処方例16の成分中、製造例1の抽出物1.0部に代えて、製造例2の抽出物1.0部を用いるほかは処方例16と同様にしてシワ改善用クリームを得た。
Prescription example 17. Wrinkle-improving cream Wrinkle-improving cream prepared in the same manner as in Formulation Example 16, except that 1.0 part of the extract of Production Example 2 was used in place of 1.0 part of the extract of Production Example 1 among the ingredients of Formulation Example 16. I got it.
処方例18.シワ改善用クリーム
処方例16の成分中、製造例1の抽出物1.0部に代えて、製造例3の抽出物1.0部を用いるほかは処方例16と同様にしてシワ改善用クリームを得た。
Prescription example 18. Wrinkle-improving cream Wrinkle-improving cream prepared in the same manner as Prescription Example 16 except that 1.0 part of the extract of Production Example 3 was used instead of 1.0 part of the extract of Production Example 1 among the ingredients of Prescription Example 16. I got it.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2022068511A JP2023158585A (en) | 2022-04-18 | 2022-04-18 | Topical skin preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2022068511A JP2023158585A (en) | 2022-04-18 | 2022-04-18 | Topical skin preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2023158585A true JP2023158585A (en) | 2023-10-30 |
Family
ID=88509405
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022068511A Pending JP2023158585A (en) | 2022-04-18 | 2022-04-18 | Topical skin preparation |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2023158585A (en) |
-
2022
- 2022-04-18 JP JP2022068511A patent/JP2023158585A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6166506B2 (en) | Topical skin preparation | |
JP5517119B2 (en) | Cosmetics | |
JP4495925B2 (en) | Collagen and elastin production promoter and anti-aging cosmetic containing the same | |
JP4755845B2 (en) | A cosmetic comprising a testosterone-5α-reductase inhibitor and a testosterone-5α-reductase inhibitor. | |
JP2015160821A (en) | Whitening composition and cosmetic | |
JP5900915B2 (en) | Whitening cosmetics | |
JP6571321B2 (en) | External composition for skin and oral composition | |
JP2006143670A (en) | Skin lotion | |
JP6723679B2 (en) | Cosmetics | |
KR20090097483A (en) | Composition comprising the mixed extract comprising mylabris sidae fabricius showing reduced toxicity for treating and improving leukoplakia | |
JP6559948B2 (en) | Skin turnover improver | |
JP7257657B2 (en) | antioxidants and cosmetics | |
JP2023158585A (en) | Topical skin preparation | |
JP5057638B2 (en) | Topical skin preparation | |
JP2024015465A (en) | Skin external preparations | |
JP4773670B2 (en) | Elastin-like agent and cosmetics containing the same | |
JP5074163B2 (en) | Cosmetics | |
JP5629489B2 (en) | Cosmetics | |
JP2022138725A (en) | External preparation for skin | |
JP2022047468A (en) | Skin external preparation | |
JP2023041502A (en) | Topical skin preparation | |
JP2023108695A (en) | Topical skin preparation | |
JP2023118164A (en) | External composition for skin | |
JP2022189201A (en) | Skin preparation for external use and hair-growing agent | |
JP2023102221A (en) | Topical skin preparation |